Clinical utility of circulating cell-free DNA in advanced colorectal cancer.
Allan Andresson Lima PereiraMaria Pia MorelliMichael OvermanBryan KeeDavid FogelmanEduardo VilarImad ShureiqiKanwal RaghavCathy EngShanequa ManuelShadarra CrosbyRobert A WolffKimberly BanksRichard LanmanAmirAli TalasazScott KopetzVan MorrisPublished in: PloS one (2017)
cfDNA sequencing can provide timely information on potentially actionable mutations and amplifications, thereby facilitating clinical trial enrollment and improving the perceived quality of care.